Εμφανίζονται 1 - 2 Αποτελέσματα από 2 για την αναζήτηση '"хроническая тромбоэмболическая легочная гипертензия (ХТЭЛГ)"', χρόνος αναζήτησης: 0,50δλ Περιορισμός αποτελεσμάτων
  1. 1
    Academic Journal
  2. 2
    Academic Journal

    Πηγή: Diagnostic radiology and radiotherapy; Том 13, № 4 (2022); 65-74 ; Лучевая диагностика и терапия; Том 13, № 4 (2022); 65-74 ; 2079-5343

    Περιγραφή αρχείου: application/pdf

    Relation: https://radiag.bmoc-spb.ru/jour/article/view/805/575; Kim N.H., Delcroix M., Jais X., Madani M.M., Matsubara H., Mayer E. et al. Chronic thromboembolic pulmonary hypertension // European Respiratory Journal. 2019. Vol. 53, No. 1. Р. 1801915. doi:10.1183/13993003.01915-2018.; Lang I.M., Pesavento R., Bonderman D. et al. Risk factors and basic mechanisms of chronic thromboembolic pulmonary hypertension: a current understanding // European Respiratory Journal. 2013. Vol. 41. Р. 462–468. doi:10.1183/09031936.00049312.; von Siebenthal C., Aubert J-D., Mitsakis P., Yerly P., Prior J.O., Nicod L.P. Pulmonary Hypertension and Indicators of Right Ventricular Function // Front. Med. 2016. Vol. 3. Р. 23. doi:10.3389/fmed.2016.00023.; Delcroix M., Vonk Noordegraaf A., Fadel E., Lang I., Simonneau G., Naeije R. Vascular and right ventricular remodelling in chronic thromboembolic pulmonary hypertension // Eur. Respir. J. 2013. Vol. 41, No. 1. Р. 224–232. doi:10.1183/09031936.00047712.; Matthews D.T., Hemnes A.R. Current concepts in the pathogenesis of chronic thromboembolic pulmonary hypertension // Pulm Circ. 2016. Vol. 6, No. 2. Р. 145–154. doi:10.1086/686011; Farrell C., Balasubramanian A., Hays A.G., Hsu S., Rowe S., Zimmerman S.L. et al. A Clinical Approach to Multimodality Imaging in Pulmonary Hypertension // Front. Cardiovasc. Med. 2022. Vol. 8. Р. 794706. doi:10.3389/fcvm.2021.794706.; Xu W., Janocha A.J., Erzurum S.C. Metabolism in pulmonary hypertension // Annu Rev Physiol. 2021. Vol. 83. Р. 551–576. doi:10.1146/annurev-physiol-031620-123956.; Farha S., Comhair S., Hou Y., Park M.M., Sharp J., Peterson L. et al. Metabolic endophenotype associated with right ventricular glucose uptake in pulmonary hypertension // Pulmonary Circulation. 2021. Vol. 11. Р. 1–12. doi:10.1177/20458940211054325; Koop A.C., Bossers G.P.L., Ploegstra M-J., Hagdorn Q.A.J., Berger R.M.F., Silljé H.H.W. et al. Metabolic Remodeling in the Pressure-Loaded Right Ventricle: Shifts in Glucose and Fatty Acid Metabolism-A Systematic Review and Meta-Analysis // J. Am. Heart Assoc. 2019. Vol. 8, No. 21. Р. e012086. doi:10.1161/JAHA.119.012086.; Piao L., Fang Y.H., Cadete V.J., Wietholt C., Urboniene D., Toth P.T. et al. The inhibition of pyruvate dehydrogenase kinase improves impaired cardiac function and electrical remodeling in two models of right ventricular hypertrophy: resuscitating the hibernating right ventricle // J. Mol. Med. (Berl). 2010. Vol. 88, No. 1. Р. 47–60. doi:10.1007/s00109-009-0524-6.; Oikawa M., Kagaya Y., Otani H., Sakuma M., Demachi J., Suzuki J. et al. Increased [18F]fluorodeoxyglucose accumulation in right ventricular free wall in patients with pulmonary hypertension and the effect of epoprostenol // J Am Coll Cardiol. 2005. Vol. 45. Р. 1849–1855. doi:10.1016/j.jacc.2005.02.065.; Saygin D., Highland K.B., Farha S., Park M., Sharp J., Roach E.C. et al. Metabolic and functional evaluation of the heart and lungs in pulmonary hypertension by gated 2-[18F]-Fluoro-2-deoxy-D-glucose positron emission tomography // Pulm. Circ. 2017. Vol. 7. Р. 428–438. doi:10.1177/2045893217701917.; Tatebe S., Fukumoto Y., Oikawa-Wakayama M., Sugimura K., Satoh K., Miura Y. et al. Enhanced [18F]fluorodeoxyglucose accumulation in the right ventricular free wall predicts long-term prognosis of patients with pulmonary hypertension: a preliminary observational study // Eur. Heart J. Cardiovasc Imaging. 2014. Vol. 15. Р. 666–672. doi:10.1093/ehjci/jet276.; Kluge R., Barthel H., Pankau H., Seese A., Schauer J., Wirtz H. et al. Different mechanisms for changes in glucose uptake of the right and left ventricular myocardium in pulmonary hypertension // J. Nucl. Med. 2005. Vol. 46, No. 1. Р. 25–31.; Oguz M., Kivrak T., Sunbul M., Dede F., Yildizeli B., Mutlu B. Diagnostic modality for evaluation of right ventricle in chronic thromboembolic pulmonary hypertension patients // Int. J. Cardiovasc. Acad. 2019. Vol. 5. Р. 152–158. doi:10.4103/IJCA.IJCA_35_19.; Ahmadi A., Thornhill R.E., Pena E., Renaud J.M., Promislow S., Chandy G. et al. Effects of Riociguat on Right Ventricular Remodelling in Chronic Thromboembolic Pulmonary Hypertension Patients: A Prospective Study // Can. J. Cardiol. 2018. Vol. 34, No. 9. doi:10.1016/j.cjca.2018.06.007.; Молокова Е.Р., Симакова М.А., Моисеева О.М., Рыжкова Д.В. Исследование перфузии и метаболизма правого желудочка методом позитронной эмиссионной томографии при хронической тромбоэмболической легочной гипертензии // REJR. 2022. Т. 12, № 2. С. 74–84. doi:10.21569/2222-7415-2022-12-2-74-84.; Vitale G.D., deKemp R.A., Ruddy T.D., Williams K., Beanlands R.S.B. Myocardial Glucose Utilization and Optimization of 18F-FDG PET Imaging in Patients with Non– Insulin-Dependent Diabetes Mellitus, Coronary Artery Disease, and Left Ventricular Dysfunction // Journal of Nuclear Medicine. 2001. Vol. 42, No. 12. Р. 1730–1736.; Li W., Wang L., Xiong C.M., Yang T., Zhang Y., Gu Q. et al. The Prognostic Value of 18F-FDG Uptake Ratio Between the Right and Left Ventricles in Idiopathic Pulmonary Arterial Hypertension // Clin. Nucl. Med. 2015. Vol. 40, No. 11. Р. 859–863. doi:10.1097/RLU.0000000000000956. PMID: 26359560.; Condliffe R., Kiely D.G., Gibbs J.S.R., Corris P.A., Peacock A.J., Jenkins D.P. et al. Prognostic and aetiological factors in chronic thromboembolic pulmonary hypertension // European Respiratory Journal. 2009. Vol. 33. Р. 332–338. doi:10.1183/09031936.00092008.; Kazimierczyk R., Szumowski P., Nekolla S.G. et al. Prognostic role of PET/MRI hybrid imaging in patients with pulmonary arterial hypertension // Heart. 2021. Vol. 107. Р. 54–60. doi:10.1136/heartjnl-2020-316741.